Bank Of America Corp Vbi Vaccines Inc Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.29 - $0.64 $71,572 - $157,952	246,800 Added 133.0%	432,370 $129,000
Q4 2022 Feb 10, 2023	SELL	$0.38 - $22.5 $77,284 - $4.58 Million	-203,381 Reduced 52.29%	185,570 $72,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $23.4 $85,146 - $2.73 Million	116,639 Added 42.83%	388,951 $273,000
Q2 2022 Aug 12, 2022	SELL	$0.66 - $1.81 $354,494 - $972,174	-537,113 Reduced 66.36%	272,312 $220,000
Q1 2022 May 16, 2022	BUY	$1.27 - $2.47 $483,665 - $940,672	380,839 Added 88.86%	809,425 $1.34 Million
Q4 2021 Feb 08, 2022	BUY	$2.21 - $3.22 $518,275 - $755,135	234,514 Added 120.84%	428,586 $1 Million
Q3 2021 Nov 15, 2021	BUY	$2.8 - $3.72 $343,268 - $456,057	122,596 Added 171.52%	194,072 $604,000
Q2 2021 Sep 13, 2021	BUY	$2.61 - $4.17 $186,552 - $298,054	71,476 New	71,476 $239,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.